Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-17

Clinical Trial Update: VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study assessing effects of combining efavirenz and tenofovir disoproxil fumarate with different doses of telaprevir in healthy vol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Incivek (telaprevir)
  • Sustiva (efavirenz)
  • Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C, HCV | Phase 1 | Status: COMPLETED